Exagen Inc

Stocks Under $10 Biotech Stocks Healthcare Stocks

$8.48

-0.24 (-2.75%)

As of Sep 28, 10:20 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target +500.5% upside

Low Target $37.48

Average Target $50.92

High Target $70.07

Current Price $8.48

Current
$8.48

Target
$50.92

$37.48 $50.92 avg $70.07

Scenario Analysis

Bear Case

$37.48

342.0%

Low target

Base Case

$50.92

+500.5%

Avg target

Bull Case

$70.07

+726.3%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$12.23

-30.7% from high

52-Week Low

$2.59

+227.4% from low

Target vs 52W High

$50.92

+316.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-3.3%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.4%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+138.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.8%
MRNA Moderna Inc	Hold	30	37%	$149.45	-24.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-43.4%